Phase IIIA FIH Nivo Combo Study
ClinicalTrials.gov NCT03400332
Research payments
$596,758
Through program year 2019, $596,758 in research payments was reported against Phase IIIA FIH Nivo Combo Study, across 12 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- NCT03400332
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $596,758 | 12 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Sridhar Beeram San Antonio, TX Named on 1 payment
- Jason Melear Austin, TX Named on 1 payment
- Stephen Richey Fort Worth, TX Named on 1 payment
- Nicholas Vogelzang Las Vegas, NV Named on 1 payment
- Donald Richards Tyler, TX Named on 1 payment
- Carlos Becerra Dallas, TX Named on 1 payment
- Paul Conkling Norfolk, VA Named on 1 payment
- John Wallmark Rockville, MD Named on 1 payment
- Alexander Spira Fairfax, VA Named on 1 payment
- William Edenfield Greenville, SC Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.